80 FR 18654 - Advisory Committee on the Medical Uses of Isotopes; Call for Nominations

NUCLEAR REGULATORY COMMISSION

Federal Register Volume 80, Issue 66 (April 7, 2015)

Page Range		18654-18655
FR Document		2015-07993

The U.S. Nuclear Regulatory Commission (NRC) is advertising for nominations for the position of Nuclear Pharmacist on the Advisory Committee on the Medical Uses of Isotopes (ACMUI). Nominees should be a currently practicing nuclear pharmacist.

Federal Register, Volume 80 Issue 66 (Tuesday, April 7, 2015)

[Federal Register Volume 80, Number 66 (Tuesday, April 7, 2015)]
[Notices]
[Pages 18654-18655]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2015-07993]


-----------------------------------------------------------------------

NUCLEAR REGULATORY COMMISSION


Advisory Committee on the Medical Uses of Isotopes; Call for 
Nominations

AGENCY: U.S. Nuclear Regulatory Commission.

ACTION: Call for Nominations.

-----------------------------------------------------------------------

SUMMARY: The U.S. Nuclear Regulatory Commission (NRC) is advertising 
for nominations for the position of Nuclear Pharmacist on the Advisory 
Committee on the Medical Uses of Isotopes (ACMUI). Nominees should be a 
currently practicing nuclear pharmacist.

[[Page 18655]]


DATES: Nominations are due on or before June 8, 2015.

NOMINATION PROCESS: Submit an electronic copy of resume or curriculum 
vitae to Ms. Sophie Holiday, Sophie.Holiday@nrc.gov. Please ensure that 
the resume or curriculum vitae includes the following information, if 
applicable: Education; certification; professional association 
membership and committee membership activities; duties and 
responsibilities in current and previous clinical, research, and/or 
academic position(s).

FOR FURTHER INFORMATION CONTACT: Ms. Sophie Holiday, U.S. Nuclear 
Regulatory Commission, Office of Nuclear Material Safety and 
Safeguards; telephone (404) 997-4691; email: Sophie.Holiday@nrc.gov.

SUPPLEMENTARY INFORMATION: The ACMUI Nuclear Pharmacist provides advice 
on issues associated with the regulation of nuclear pharmacy 
applications of byproduct material. This advice includes providing 
input on NRC proposed rules and guidance, providing recommendations on 
the training and experience requirements for Authorized Nuclear 
Pharmacists, identifying medical events associated with these uses, 
evaluating non-routine uses of byproduct material, bringing key issues 
in the nuclear pharmacy community to the attention of NRC staff, as 
they relate to radiopharmaceuticals, radiation safety and NRC medical-
use policy.
    ACMUI members are selected based on their educational background, 
certification(s), work experience, involvement and/or leadership in 
professional society activities, and other information obtained in 
letters or during the selection process.
    ACMUI members possess the medical and technical skills needed to 
address evolving issues. The current membership is comprised of the 
following professionals: (a) Nuclear medicine physician; (b) nuclear 
cardiologist; (c) two radiation oncologists; (d) diagnostic 
radiologist; (e) therapy medical physicist; (f) nuclear medicine 
physicist; (g) nuclear pharmacist; (h) health care administrator; (i) 
radiation safety officer; (j) patients' rights advocate; (k) Food and 
Drug Administration representative; and (l) Agreement State 
representative.
    NRC is inviting nominations for the Nuclear Pharmacist to the 
ACMUI. The term of the individual currently occupying this position 
will end March 29, 2016. Committee members currently serve a four-year 
term and may be considered for reappointment to an additional term.
    Nominees must be U.S. citizens and be able to devote approximately 
160 hours per year to Committee business. Members who are not Federal 
employees are compensated for their service. In addition, members are 
reimbursed for travel (including per-diem in lieu of subsistence) and 
are reimbursed secretarial and correspondence expenses. Full-time 
Federal employees are reimbursed travel expenses only.
    Security Background Check: The selected nominee will undergo a 
thorough security background check. Security paperwork may take the 
nominee several weeks to complete. Nominees will also be required to 
complete a financial disclosure statement to avoid conflicts of 
interest.

    Dated at Rockville, Maryland, this 1st day of April, 2015.

    For the U.S. Nuclear Regulatory Commission.
Andrew L. Bates,
Advisory Committee Management Officer.
[FR Doc. 2015-07993 Filed 4-6-15; 8:45 am]
BILLING CODE CODE 7590-01-P

Federal Register / Vol. 80, No. 66 / Tuesday, April 7, 2015 / Notices 18655

DATES: Nominations are due on or Nominees must be U.S. citizens and Regulatory Commission, Office of
before June 8, 2015. be able to devote approximately 160 Nuclear Material Safety and Safeguards;
hours per year to Committee business. telephone: (404) 997–4691, email:
NOMINATION PROCESS: Submit an
Members who are not Federal sophie.holiday@nrc.gov.
electronic copy of resume or curriculum
employees are compensated for their
vitae to Ms. Sophie Holiday, Conduct of the Meeting
service. In addition, members are
Sophie.Holiday@nrc.gov. Please ensure Dr. Bruce Thomadsen, ACMUI
reimbursed for travel (including per-
that the resume or curriculum vitae Chairman, will preside over the
diem in lieu of subsistence) and are
includes the following information, if reimbursed secretarial and meeting. Dr. Thomadsen will conduct
applicable: Education; certification; correspondence expenses. Full-time the meeting in a manner that will
professional association membership Federal employees are reimbursed travel facilitate the orderly conduct of
and committee membership activities; expenses only. business. The following procedures
duties and responsibilities in current Security Background Check: The apply to public participation in the
and previous clinical, research, and/or selected nominee will undergo a meeting:
academic position(s). thorough security background check. 1. Persons who wish to provide a
FOR FURTHER INFORMATION CONTACT: Ms. Security paperwork may take the written statement should submit an
Sophie Holiday, U.S. Nuclear nominee several weeks to complete. electronic copy to Ms. Holiday at the
Regulatory Commission, Office of Nominees will also be required to contact information listed above. All
Nuclear Material Safety and Safeguards; complete a financial disclosure submittals must be received by June 11,
telephone (404) 997–4691; email: statement to avoid conflicts of interest. 2015, three business days prior to the
Sophie.Holiday@nrc.gov. Dated at Rockville, Maryland, this 1st day meeting, and must pertain to the topic
SUPPLEMENTARY INFORMATION: The of April, 2015. on the agenda for the meeting.
ACMUI Nuclear Pharmacist provides For the U.S. Nuclear Regulatory 2. Questions and comments from
advice on issues associated with the Commission. members of the public will be permitted
regulation of nuclear pharmacy Andrew L. Bates, during the meetings, at the discretion of
applications of byproduct material. This Advisory Committee Management Officer. the Chairman.
advice includes providing input on NRC [FR Doc. 2015–07993 Filed 4–6–15; 8:45 am] 3. The draft transcript and meeting
proposed rules and guidance, providing BILLING CODE CODE 7590–01–P
summary will be available on ACMUI’s
recommendations on the training and Web site http://www.nrc.gov/reading-
experience requirements for Authorized rm/doc-collections/acmui/meetings/
Nuclear Pharmacists, identifying NUCLEAR REGULATORY 2015.html on or about July 29, 2015.
medical events associated with these COMMISSION This meeting will be held in
uses, evaluating non-routine uses of accordance with the Atomic Energy Act
byproduct material, bringing key issues Advisory Committee on the Medical of 1954, as amended (primarily Section
in the nuclear pharmacy community to Uses of Isotopes: Meeting Notice 161a); the Federal Advisory Committee
the attention of NRC staff, as they relate AGENCY: U.S. Nuclear Regulatory Act (5 U.S.C. App); and the
to radiopharmaceuticals, radiation Commission. Commission’s regulations in Title 10 of
safety and NRC medical-use policy. the Code of Federal Regulations Part 7.
ACTION: Notice of meeting.
ACMUI members are selected based Dated at Rockville, Maryland, this 1st day
on their educational background, SUMMARY: The U.S. Nuclear Regulatory of April, 2015.
certification(s), work experience, Commission will convene a For the U.S. Nuclear Regulatory
involvement and/or leadership in teleconference meeting of the Advisory Commission.
professional society activities, and other Committee on the Medical Uses of Andrew L. Bates,
information obtained in letters or during Isotopes (ACMUI) on June 16, 2015, to
Advisory Committee Management Officer.
the selection process. discuss the ACMUI Radioactive Seed
[FR Doc. 2015–07990 Filed 4–6–15; 8:45 am]
ACMUI members possess the medical Localization subcommittee report and to
hear a presentation from Spectrum BILLING CODE CODE 7590–01–P
and technical skills needed to address
evolving issues. The current Pharmaceuticals regarding the training
membership is comprised of the and experience requirements for alpha
and beta emitters. Meeting information, NUCLEAR REGULATORY
following professionals: (a) Nuclear COMMISSION
medicine physician; (b) nuclear including a copy of the agenda and
cardiologist; (c) two radiation handouts, will be available at http://
www.nrc.gov/reading-rm/doc- [NRC–2015–0058]
oncologists; (d) diagnostic radiologist;
(e) therapy medical physicist; (f) nuclear collections/acmui/meetings/2015.html.
Applications and Amendments to
medicine physicist; (g) nuclear The agenda and handouts may also be
Facility Operating Licenses and
pharmacist; (h) health care obtained by contacting Ms. Sophie
Combined Licenses Involving
administrator; (i) radiation safety officer; Holiday using the information below.
Proposed No Significant Hazards
(j) patients’ rights advocate; (k) Food DATES: The teleconference meeting will
Considerations and Containing
and Drug Administration representative; be held on Tuesday, June 16, 2015, 2:00 Sensitive Unclassified Non-Safeguards
and (l) Agreement State representative. p.m. to 5:00 p.m. Eastern Standard Information and Order Imposing
Time.
mstockstill on DSK4VPTVN1PROD with NOTICES

NRC is inviting nominations for the Procedures for Access to Sensitive
Nuclear Pharmacist to the ACMUI. The Public Participation: Any member of
Unclassified Non-Safeguards
term of the individual currently the public who wishes to participate in
Information
occupying this position will end March the teleconference should contact Ms.
29, 2016. Committee members currently Holiday using the contact information AGENCY: Nuclear Regulatory
serve a four-year term and may be below. Commission.
considered for reappointment to an FOR FURTHER INFORMATION CONTACT: Ms. ACTION: License amendment request;
additional term. Sophie Holiday, U.S. Nuclear opportunity to comment, request a

VerDate Sep<11>2014 17:46 Apr 06, 2015 Jkt 235001 PO 00000 Frm 00070 Fmt 4703 Sfmt 4703 E:\FR\FM\07APN1.SGM 07APN1

Document Created: 2018-02-21 10:05:00
Document Modified: 2018-02-21 10:05:00

Category		Regulatory Information
Collection		Federal Register
sudoc Class		AE 2.7: GS 4.107: AE 2.106:
Publisher		Office of the Federal Register, National Archives and Records Administration
Section		Notices
Action		Call for Nominations.
Dates		Nominations are due on or before June 8, 2015.
Contact		Ms. Sophie Holiday, U.S. Nuclear Regulatory Commission, Office of Nuclear Material Safety and Safeguards; telephone (404) 997-4691; email: [email protected]
FR Citation		80 FR 18654